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Abstract

The gadolinium-based contrast agent (GdBCA) Omniscan activates human macrophages
through TLR4 and TLR7 signaling. To explore the mechanisms responsible we compared
the ability of linear and macrocyclic GdBCA to induce a type I interferon signature and a
proinflammatory/profibrotic phenotype in normal human monocytes in vitro. Expression of
genes associated with type I interferon signaling and inflammation, and production of their
corresponding proteins were determined. Both linear and macrocyclic GdBCA stimulated
expression of multiple type I interferon regulated genes and the expression of numerous
chemokines, cytokines and growth factors in normal human peripheral blood monocytes.
There was no correlation between the magnitude of the measured response and the Gd
chelate used. To explore the mechanisms responsible for GdBCA induction of fibrosis in
Nephrogenic Systemic Fibrosis (NSF) in vitro, normal human dermal fibroblasts were
incubated with GdBCA-treated monocyte culture supernatants and the effects on profibrotic
gene expression were examined.

Supernatants from monocytes exposed to all GdBCA

stimulated types I and III collagen, fibronectin and -SMA expression in normal dermal
fibroblasts. The results indicate that the monocyte activation induced by GdBCA may be
the initial step in the development of GdBCA associated fibrosis in NSF.
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Introduction
Nephrogenic Systemic Fibrosis (NSF) is a systemic fibrosing disorder occurring in
patients with chronic kidney disease (CKD) characterized by progressive fibrosis of skin,
periarticular tissues, striated muscles and various internal organs (1-4). Histopathological
studies of affected NSF skin demonstrate severe dermal and subdermal fibrosis, prominent
mucin deposition, accumulation of activated fibroblasts and macrophages, and strikingly
increased in situ expression of transforming growth factor beta (TGF-)(3). Although the
exact mechanisms responsible for NSF development are not known the majority of reported
cases occurred following exposure to high doses of Gd based contrast agents (GdBCA) in
the context of renal insufficiency (5-8). Gd accumulation in CKD patient tissues is thought
to be the primary event in NSF pathogenesis. Indeed, numerous studies have described Gd
deposition in affected tissues from NSF patients (9-11).
Two models that differ in the nature of the bioactive form of Gd associated with
NSF occurrence in CKD individuals have been proposed (12-16). The transmetallation
model posits that GdBCA accumulate in the extravascular space and tissues where
endogenous free cations such as Zn2+, Ca2+, Cu2+, or Fe2+ displace Gd3+ from the chelate
complex (12-15). The Gd3+ released from the chelate complex can induce activation of
various profibrotic molecular pathways in one or more of the cell types present in fibrotic
NSF lesions, such as macrophages, fibroblasts and fibrocytes. According to this model, less
thermodynamically stable linear GdBCA are more prone to undergo transmetallation
thereby initiating the fibrotic process leading to NSF. The second model, the chelate model,
proposes that intact Gd chelate complexes, rather than transmetallated Gd3+, are the
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bioactive agent triggering the NSF fibrotic process (16). This model suggests that certain
intrinsic property(s) of the intact Gd chelate complex is(are) responsible for the
disproportionately greater association of linear GdBCA with NSF development compared
to macrocyclic GdBCA based on exposure rates to these classes of agents.
Activated macrophage infiltration into affected NSF skin and visceral tissues (3)
and the induction of a proinflammatory/profibrotic phenotype in normal human peripheral
monocytes and macrophages by the linear contrast agents Omniscan and Gd-DTPA have
been previously described (17,18). Recently, it has been reported that Omniscan stimulation
of production of proinflammatory/profibrotic cytokines, chemokines and growth factors is
mediated by TLR4 and TLR7 in normal differentiated human macrophages (19). Numerous
other studies have demonstrated that GdBCA can induce profibrotic responses in normal
and NSF fibroblasts as well as in skin organ cultures (20-23). However, the induction of a
Type I interferon signature, and a detailed comparison of proinflammatory and profibrotic
effects of various linear and macrocyclic GdBCA have not been performed. Thus, the
purpose of the present study was to compare the ability of four different linear GdBCA and
two different macrocyclic GdBCA to induce a Type I interferon signature and the
expression of a proinflammatory/profibrotic phenotype in normal human monocytes in
vitro. Furthermore, the effects of supernatants from these cells on cultured normal human
dermal fibroblasts were examined to explore the mechanisms that might be responsible for
the differential association of various GdBCA agents with NSF development.
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Experimental
Gd compounds.

Dotarem® (Guerbet LLC, Bloomington, IL) , MultiHance® (Bracco

Diagnostics, Milan, IT), ProHance® (Bracco Diagnostics, Milan, IT), OptiMark®
(Mallinckrodt Inc/Covidien, Hazelwood, IN), were supplied as sterile, aqueous solutions
each containing 500 mM of the Gd chelate. Omniscan® and gadodiamide (provided by GE
Healthcare, Chalfont St. Giles, UK) were supplied as sterile, aqueous solutions each
containing 287 mg/ml (500 mM) gadodiamide. The Omniscan® solution contained an
additional 12 mg/ml (25 mM) caldiamide sodium in water. Caldiamide (GE Healthcare)
was supplied as a sterile aqueous solution containing 12 mg/ml (25 mM) caldiamide
sodium in water. Gd-EDTA (GE Healthcare) was supplied as a sterile aqueous solution
containing 250 mM Gd-EDTA in water. Gd-Citrate (250 µM) was prepared by mixing 1
mL of 250 µM gadolinium chloride and 1 mL of 500 µM sodium citrate solutions at pH 7.4
(24).

Gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA; Sigma-Aldrich. St.

Louis, MO), the Gd chelate used in Magnevist®, was dissolved in sterile PBS solution at
0.5M concentration. The reagents employed for all the studies were tested and verified by
the manufacturer to be free from endotoxin contamination. The absence of endotoxin
contamination was further confirmed in our laboratories utilizing the Etoxate Assay
(Sigma-Aldrich) according to the manufacturer’s instructions.
Monocyte Isolation.

Leukoreduction filters from three different normal donors were

obtained from the Thomas Jefferson University Hospital Blood Bank following
Institutional Review Board approval. Human peripheral blood mononuclear cells (PBMC)
were isolated from the filters by Ficoll-Hypaque gradient centrifugation (Amersham
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Pharmacia Biotech, Piscataway, NJ) and enriched for monocytes by adherence to plastic
culture dishes for 2 h as described (17,25).
Treatment of monocytes with Gd compounds. Equal numbers of monocytes were plated
in 60 mm plastic culture dishes in RPMI 1640 media supplemented with 25 mM HEPES,
L-glutamine and 10% FBS. Lipopolysaccharide (LPS;1 μg/ml) was the positive control and
sterile saline was the negative control. Cells were exposed for 12 h or 24 h to 5 mM of each
of the six GdBCA or to 250 µM caldiamide which corresponds to the amount present in the
Omniscan® preparation. Total RNA was isolated from the cells exposed to GdBCA for 12
h as previously described (17,18) and supernatants from each sample were collected and
stored at -20oC until used.
Enzyme-linked immunosorbent assay. SearchLight ELISA proteome array analyses
(Pierce Biotechnology, Woburn, MA) were performed as described previously (17,18) to
quantitate the levels of IL-4, IL-6, IL-13, IFN-, TGF-β, and VEGF in supernatants from
monocytes exposed to the Gd compounds for 24 h. Briefly, samples were diluted 1:2, 1:50,
and 1:1,000 and then incubated for 1 h on the array plates which had been prespotted with
capture antibodies specific for each protein. Plates were decanted and washed 3 times with
PBS before addition of a mixture of biotinylated detection antibodies to each well.
Following incubation with detection antibodies for 30 min, plates were washed 3 times and
incubated for 30 min with streptavidin–horseradish peroxidase. Plates were again washed
and SuperSignal Femto chemiluminescent substrate was added. The plates were
immediately imaged using the SearchLight imaging system and data were analyzed using
ArrayVision software.
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Real-time polymerase chain reaction (PCR). Monocyte and fibroblast transcript levels
were quantified using SYBR Green real time PCR, as previously described (17,18). Primers
were designed using Primer Express software (Applied Biosystems, Foster City, CA) and
validated for specificity The primers employed are displayed in Supplemental Table 1. The
differences in the number of mRNA copies in each PCR were corrected for human β-actin
endogenous control transcript levels; levels in control experiments were set at 100 and all
other values expressed as multiples of control values.
Treatment of cultured fibroblasts with conditioned media from peripheral blood
monocytes exposed to Gd compounds. Two normal human dermal fibroblast cell lines
(passages 4-10) from the Scleroderma Center Tissue Bank, Thomas Jefferson University,
were cultured in Dulbecco’s modified Eagle’s (MEM) medium supplemented with 10%
fetal bovine serum, antibiotics, 50 mM HEPES, and glutamine until confluent.
For experiments, the cells were cultured in complete medium in 6-well plastic plates until
confluence. Following preincubation for 24 h with 40 μg/ml ascorbic acid (Sigma-Aldrich)
to optimize collagen production, fibroblasts were incubated for 24 h with conditioned
media from Gd-exposed peripheral blood monocytes at a 1:2 dilution. Fibroblasts were
then were harvested with trypsin-EDTA, washed with PBS, and then processed for RNA
extraction using the RNeasy kit (Qiagen, Valencia, CA) as described previously (17,18).
Statistical analysis. Real-time PCR values reflect the mean and standard deviation of three
separate experiments each performed in triplicate with each of the three samples of normal
human macrophages. The statistical significance of the real-time PCR data was assessed by
Student’s two-tailed t test. P values less than 0.05 were considered statistically significant.
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Results
Effects of Gd compounds on cytokine and growth factor gene expression levels
in normal human monocytes. Expression levels of profibrotic/proinflammatory cytokines
in normal human monocytes in response to 12 h exposure to Gd-containing agents were
analyzed by real time PCR. IL-6 and IL-13 were markedly increased in response to all Gd
compounds whereas VEGF was increased by all Gd compounds except MultiHance and
OptiMARK (Figure 1). IL-4 was increased by all Gd compounds except Gd-DTPA,
MultiHance and OptiMARK whereas TGF was increased only in response to Omniscan,
gadodiamide, Gd-EDTA and Gd-Citrate. IFN-, however, was increased only in response
to Gd-DTPA, Dotarem and ProHance. No correlation between the level of induction of
expression of various genes encoding the proinflammatory/profibrotic cytokines and
growth factors and the structure of the GdBCA chelate molecule or the non-chelated Gd
compound was observed. Exposure of monocytes to caldiamide had no effect on the
expression level of any gene measured.
Effects of Gd compounds on chemokine gene expression levels by normal
human monocytes. Expression levels of chemokine genes in normal human monocytes in
response to 12 h exposure to Gd-containing agents were analyzed by real time PCR.
CXCL9 and CXCL12 were markedly increased in response to all Gd compounds whereas
CCL2 was increased by all Gd compounds except Gd-DTPA and CCL8 was increased by
all Gd compounds except OptiMARK (Figure 2). CXCL11 was increased by all Gd
compounds except MultiHance and Dotarem whereas CXCL10 was increased only in
response to Gd-DTPA, Omniscan, gadodiamide, Gd-EDTA and Gd-Citrate.

8

As with

expression levels of cytokines and growth factors, no correlation between the level of
response attained and the structure of the chelate molecule of the GdBCA was observed.
Effects of Gd compounds on normal human monocyte production of
proinflammatory/profibrotic cytokines and chemokines. To assess whether the effects
observed at the gene expression level were also reflected at the protein level, the amounts
of cytokines and growth factors present in culture supernatants isolated from normal human
monocytes incubated for 24 h with the Gd compounds were assayed by SearchLight
proteome multiplex arrays (Figure 3). The levels of IL4, IL13, and TGF produced were
significantly elevated by all of the GdBCA tested, regardless of the chelate class (Figure
3), and all agents except for OptiMARK induced increased VEGF levels whereas only
Omniscan, gadodiamide and ProHance significantly induced increased production of IL-6.
Omniscan and gadodiamide treated cells produced the highest levels of IL-4, IL-6, and IL13, whereas, Omniscan, gadodiamide and MultiHance produced the highest levels of
VEGF.
Conditioned media from Gd-stimulated normal human monocytes induce a
profibrotic phenotype in normal human dermal fibroblasts. Fibroblasts cultured with
supernatants from monocytes that had been exposed to linear and macrocyclic GdBCA or
to nonchelated Gd compounds displayed increased expression of type I and type III human
collagen (COL1A and COL3A) respectively. All monocyte supernatants caused collagen
gene expression stimulation with similar efficacy (Figure 4). Similarly, -smooth muscle
actin (-SMA) expression, a marker of myofibroblast activation, and fibronectin (FN1)
expression were upregulated by all of the GdBCA, although supernatants from cells

9

exposed to the linear chelate GdBCA showed a slightly greater level of upregulation of SMA expression compared to those induced by macrocyclic GdBCA.

In contrast,

supernatants from monocytes exposed to caldiamide alone did not affect expression of any
of the genes examined in the cultured fibroblasts.
Effects of Gd compounds on expression levels of type I inteferons and of genes
involved in induction of NFB by normal human monocytes. Expression levels of type
I interferons (IFN-α and IFN-) and of the NFB activator genes, Interferon Regulatory
Factor 1 (IRF1), IRF4, IRF9 and X-linked Inhibitor of Apoptosis (XIAP) were analyzed in
normal human monocytes following 12 h exposure to Gd-containing agents. All linear
chelates and non-chelated Gd compounds induced striking increases in the expression of all
6 genes (Figure 5). In contrast, Dotarem induced increased expression of IFN-α, IFN-,
IRF4 and IRF9 but not of IRF1 or XIAP and ProHance increased expression of only IFN-α,
IFN- and IRF9.
Effects of Gd compounds on gene expression levels of interferon-responsive
genes by normal human monocytes.

Analysis of expression levels of interferon-

responsive genes in normal human monocytes in response to 12 h exposure to Gdcontaining agents were analyzed next. Expression of CCL20, Interferon Inducible 44-like
(IFI44L), Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), IL8, IL18 and
Immunoresponsive gene 1 (IRG1) were all markedly increased in response to all GdBCA
(Figure 6). No correlation was observed between the level of response attained and the
structure of the chelate molecule of the GdBCA with all linear and macrocyclic GdBCA.
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We also found that all non-chelated Gd compounds induced expression of all interferonresponsive genes.
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Discussion

Exposure to GdBCA is a crucial event in NSF pathogenesis but the mechanisms that
trigger this severe fibrotic disease are poorly understood. Multiple, non-mutually exclusive
hypotheses to explain the roles of a variety of molecular pathways and possible cofactors in
NSF pathogenesis have been proposed (reviewed in 12-16, 26, 27). One area of debate
concerns the form of the active Gd molecule. The transmetallation hypothesis proposes that
free Gd3+ is the active form (12-15) whereas the chelate hypothesis posits the intact Gd
chelate molecule instead (16). The present study was designed to compare the relative
abilities of linear and macrocyclic GdBCA to induce a proinflammatory/profibrotic
phenotype in normal human monocytes. A second goal of the studies described was to
examine the ability of the linear and macrocyclic GcBCA to affect expression levels of type
I IFNs and type I IFN responsive genes as well as genes involved in NFB expression and
NFB-mediated transcriptional activation. These studies were carried out in order to
provide a mechanistic link between the previously described GdBCA signaling through
TLR4 and TLR7 (19) and the induction of the profibrotic/proinflammatory phenotype
responsible for NSF development.

The results demonstrate that both classes of GdBCA as well as non-chelated Gd
compounds induce in normal human monocytes the expression and secretion of numerous
cytokines, chemokines and growth factors generally recognized as important mediators of
the initiation and/or progression of the fibrotic process. Further, culture supernatants
isolated from monocytes exposed to either linear or macrocyclic agents or to non-chelated
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Gd compounds were shown to stimulate type I and type III collagens and α-SMA and FN1
expression in normal human dermal fibroblasts. While we recognize that HEPES buffer
may negatively affect B-lymphocyte DNA replication, several studies have found that this
effect is observed only in the absence of CO2 (28) and that in the presence of CO2 HEPES
offers greater buffering capacity and ensures better cell survival and stimulation of cellular
proliferation (29).

Indeed, in a previous study we observed comparable levels of

stimulation of gene expression by GdBCA in human macrophages cultured in the presence
of HEPES to the results described here in human lymphocytes (19). The changes in
expression of numerous proinflammatory/profibrotic chemokines, cytokines and growth
factors and of type I interferon responsive genes were consistent in three separate
experiments utilizing monocytes derived from three different normal individuals. However,
the magnitude of the observed effects was variable among the cells from the three
individuals, possibly owing to genetic heterogeneity and variability in the sensitivity of
monocytes from different donors to the activating stimuli. These observations are consistent
with epidemiological studies showing that NSF development occurs infrequently even
among the large population of renal insufficiency patients exposed to GdBCA.

There was no correlation between the induction of proinflammatory/profibrotic
gene expression in normal human monocytes with the dynamic stability of the GdBCA as
would be expected if the active agent was free Gd3+. While some free Gd3+ release cannot
be entirely ruled out for ProHance, the thermodynamic stability of Dotarem at the acidic pH
levels found in macrophage lysosomal compartments is ~338 h (27). Therefore, if free Gd3+
is required for the induction of profibrotic molecular pathways as proposed in the
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transmetallation hypothesis, then the macrocyclic agents should have had minimal or no
detectable effects on cytokine and growth factor expression. Thus, the greater ability of
certain GcBCA to induce NSF cannot be explained simply to their enhanced susceptibility
to undergo transmetallation. It seems more likely that a unique characteristic of certain
linear GdBCA or of gadodiamide in particular, such as its shape, molecular pattern, or
molecular surface reactivity is responsible for the disproportionately high frequency of NSF
cases associated with their use.

It has recently been reported that Omniscan and gadodiamide induce TLR4 and
TLR7-dependent expression of profibrotic/proinflammatory cytokines and growth factors
in normal human differentiated macrophages (19). The results described here demonstrate
that all Gd compounds examined were capable of inducing expression of genes associated
with TLR signaling, including XIAP, which activates NFB expression in response to
TGF signaling (30), and of IRF1, IRF4 and IRF9 which are components of downstream
intracellular signaling complexes mediating NFB target gene regulation and induction of
type I IFN expression (31-34). Interestingly, exposure to all Gd compounds tested resulted
in a striking induction of the expression of type I interferon responsive genes CCL20,
IFI44L, IFIT, IL8, IL18 and IRG1. These observations are consistent with the notion that
GdBCA molecular pattern recognition by the TLR as well as a direct effect of free Gd3+
participate in NSF pathogenesis.

These results, therefore, suggest the establishment of a signaling pathway in which
GdBCA as well as non-chelated Gd compounds signal through TLR4 and TLR7, inducing
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expression of XIAP and IRF genes that mediate NFB activation. NFB activation and
signaling, in turn, induce the expression of type I interferon responsive genes that mediate
the establishment of a proinflammatory/profibrotic phenotype characterized by the
expression and production of cytokines, chemokines and growth factors capable of
triggering the activation of quiescent fibroblasts into myofibroblasts.

This putative

pathway is illustrated in Figure 7. These results are of relevance to other fibrotic disorders
such as Systemic Sclerosis (SSc) in which activation of a type I interferon pathway has
been reported (35-41).

In conclusion, the results described here demonstrate that GdBCA, regardless of
chelate class and thermodynamic stability, induce in normal human monocytes remarkably
potent

expression

of

numerous

genes

encoding

well-characterized

profibrotic/proinflammatory chemokines, cytokines and growth factors and of type I
interferons and interferon-responsive genes resulting in their increased production and
release. Furthermore, conditioned medium from monocytes exposed to the different Gdcontaining compounds caused a potent stimulation of expression of the profibrotic markers
types I and III collagen, fibronectin and -SMA in normal human dermal fibroblasts. The
observations that both linear and macrocylic classes of Gd chelates as well as the nonchelated Gd-containing compounds induce these potent cellular phenotypic and gene
expression changes in normal human macrophages indicate that GdBCA thermodynamic
stability is not likely to be the primary factor influencing the relative activity of these
compounds in the induction of NSF.

15

Acknowledgements
This work was supported by an Investigator Initiated grant from GE Healthcare and by a
grant from NIH (R21 AR-061680-01to SAJ). We thank Dr. Ben Newton for supplying
GdBCA and for stimulating discussions and constructive critical reading of the manuscript.
Disclosures
The authors have no financial conflicts of interest.

16

Figure Legends

Figure 1.

Effect of non-ionic and ionic linear and macrocyclic GdBCA on the

expression levels of various genes encoding profibrotic/proinflammatory cytokines
and growth factors in normal human monocytes. Values represent the mean (+/- SD)
expression levels of three replicates of three separate experiments with monocytes obtained
from three different normal individuals exposed to the Gd compounds for 12 h. C(t) values
for cytokines were normalized with β-actin. The saline control levels were arbitrarily set at
100% expression at each time point. Values for other samples are expressed relative to the
saline control. Expression levels of (A) IL4, (B) IL6, (C) IL13, (D) IFN, (E) TGF, and
(F) VEGF transcripts are displayed. Statistical significance of changes in cytokine and
growth factor expression as determined by Student’s T test comparing each Gd compound
to the saline control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***:
p<0.001. Caldiamide did not induce a significant effect for any cytokine or growth factor.

Figure 2.

Effect of non-ionic and ionic linear and macrocyclic GdBCA on the

expression levels of various chemokine genes in normal human monocytes. Values
represent the mean (+/- SD) expression levels of three replicates of three separate
experiments with monocytes obtained from three different normal individuals exposed to
the Gd compounds for 12 h. C(t) values for cytokines were normalized with β-actin. The
saline control levels were arbitrarily set at 100% expression at each time point. Values for
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other samples are expressed relative to the saline control. Expression levels of (A) CCL2,
(B) CCL8, (C) CXCL9, (D) CXCL10, (E) CXCL11, and (F) CXCL12 transcripts are
displayed. Statistical significance of changes in chemokine expression as determined by
Student’s T test comparing each Gd compound to the saline control appears above the
corresponding bar. *: p<0.05; **: p < 0.01; ***: p<0.001.

Caldiamide did not induce a

significant effect for any cytokine or growth factor.

Figure 3. Quantitative measurement of various cytokines and growth factors present
in the culture media of Gd-compound-exposed normal human monocytes employing
multiplex proteome array analyses. Cells were incubated with either saline, 5 mM GdDTPA, MultiHance, Omniscan, gadodiamide, Dotarem or ProHance, or 2.5 mM caldiamide
for 24 h and the culture media was assayed. Values are expressed in pg/ml and represent
the mean (+/-) value of values obtained from duplicate results of pooled samples of 3
individuals at 3 dilutions: 1:2, 1:50 and 1:1000. Statistical significance of changes in
cytokine and growth factor expression as determined by Student’s T test comparing each
Gd compound to the saline control appears above the corresponding bar. *: p<0.05; **: p <
0.01; ***: p<0.001.

Caldiamide did not induce a significant effect for any cytokine or

growth factor.

Figure 4. Effects of supernatants from monocytes exposed to Gd compounds on
expression of types I and III collagen, fibronectin and -SMA in normal dermal
human fibroblasts. Fibroblasts were incubated for 24 h in media containing a 1:2 dilution
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of culture supernatants isolated from monocytes exposed to Gd compounds for 12 h.
Expression levels of (A) COL1A1, (B) COL3A1, (C) FN1 and (D) α-SMA transcripts
determined by real time PCR. The results shown are representative of three separate
experiments, each performed in triplicate. The saline control levels were arbitrarily set at
100%. Values for the samples are expressed as the mean (+/- SD) percent increase over the
saline control value. Statistical significance of changes in cytokine and growth factor
expression as determined by Student’s T test comparing each Gd compound to the saline
control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***: p<0.001.
Supernatants from monocytes exposed to caldiamide did not induce a significant effect on
fibroblast gene expression.

Figure 5. Effects of Gd compounds on expression of XIAP and IRF family genes in
normal human monocytes. Values represent the mean (+/- SD) expression levels of three
replicates of three separate experiments with monocytes obtained from three different
normal individuals. C(t) values for cytokines were normalized with β-actin. The saline
control levels were arbitrarily set at 100% expression at each time point. Values for other
samples are expressed relative to the saline control. Expression levels of (A) IRF1, (B)
IRF4, (C) IRF9, and (D) XIAP transcripts are displayed. Statistical significance of changes
in chemokine expression as determined by Student’s T test comparing each Gd compound
to the saline control appears above the corresponding bar. *: p<0.05; **: p < 0.01; ***:
p<0.001. Caldiamide did not induce a significant effect.
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Figure 6. Effects of Gd compounds on expression of type I interferon responsive
genes in normal human monocytes. Values represent the mean (+/- SD) expression
levels of three replicates of three separate experiments with monocytes obtained from three
different normal individuals. C(t) values for cytokines were normalized with β-actin. The
saline control levels were arbitrarily set at 100% expression at each time point. Values for
other samples are expressed relative to the saline control. Expression levels of (A) CCL20,
(B) IFI44L, (C) IFIT1, (D) IL8, (E) IL18, and (F) IRG1 transcripts are displayed.
Statistical significance of changes in chemokine expression as determined by Student’s T
test comparing each Gd compound to the saline control appears above the corresponding
bar. *: p<0.05; **: p < 0.01; ***: p<0.001. Caldiamide did not induce a significant effect.

Figure 7. Pathways mediating GdBCA induction of proinflammatory/profibrotic
phenotype in normal human macrophages. Cellular recognition of either free Gd3+
(transmetallation model) or of the intact chelated GdBCA (chelate model) is mediated
through TLR4 and TLR7 signaling. The signaling events result in upregulation of XIAP
and IRF genes and activation of NFB which cooperate to upregulate type I interferons,
that in turn activate type I interferon signature genes (ISGs) resulting in production of
proinflammatory and profibrotic chemokines, cytokines and growth factors. These factors
are secreted by activated macrophages and can then act to promote the transdifferentiation
of quiescent fibroblasts to activated myofibroblasts, characterized by initiation of α-SMA
expression and in dysregulated and sustained extracellular matrix production leading to
tissue fibrosis. Figure modified from (19).
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